Duchesnay Fund

For a better use of drugs during pregnancy and lactation

The valuable support we receive from individuals and corporate sponsors helps to promote and fund research on the health and well being of pregnant women and their unborn children. Through the Duchesnay Fund, the Foundation is proud to fund research that helps ensure the safety and efficacy of drugs during pregnancy and lactation.

Duchesnay Inc., the world’s only manufacturer of pharmaceutical products dedicated exclusively to improving the quality of life of pregnant women and their children, has generously donated more than $250,000 to the Foundation over the years. Because of this vital support, important research projects have received funding.

Previous Duchesnay Fund research grants have been awarded to projects studying critical issues such as:

The use of drugs to treat post-partum depression
The use of drugs during lactation and the potential costs of misinformation
Possible side effects of certain drugs taken during breastfeeding

Under the leadership of Mr. Éric Gervais, Duchesnay’s continued support of the SOGC and the Foundation has been a key factor in our growth. Through this continued assistance we hope to further develop and expand our grants programs and - most importantly - to further improve the health and welfare of pregnant women and their unborn children.

Duchesnay Fund Awards

2004	Dr. Shinya Ito from the Hospital for Sick Children was awarded a $29,307 grant to research “Pregnancy Exposure to HMG-CoA Reductase Inhibitors: Fetal and Neonatal Outcome.”
2003	David Knoppert from the University of Western Ontario was awarded a $14,800 grant to research “Effect of domperidone on milk production in mothers of premature newborns: A comparison of 2 dosages.”
2002	Dr. Shinya Ito from The Hospital for Sick Children was awarded a $16,000 grant to research “Propylthiouracil use during breastfeeding: The cost of misinformation.”
2001	Dr. Myroslava Romach from University of Toronto was awarded a $27,000 grant research titled “An exploratory study of the effects of Sertraline or placebo on allopregnanolone levels and clinical outcome in women with postpartum depression.”
2000	Dr. Evelyne Rey was awarded a $23,000 grant for research in “Prévention par la daltéparine des complications reliées aux infractus placentaires chez les femmes sans thrombophilie documentée. (Prevention of poor obstetrical outcomes with dalteparin in women with placental infarcts and no thrombophilia.)”
1999	Dr. Shinya Ito from the Hospital for Sick Children was awarded a $19,250 grant from for research in “The maternal use of beta-blockers during breastfeeding.”